Huntington’s disease gene therapy (University of Tennessee)

N/A

Report date: 2025/03/20 15:44:57

Base Information

Drug NameHuntington’s disease gene therapy (University of Tennessee)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Tennessee
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Tennessee Research Foundation Office of Technology Transfer
Inactive CompaniesN/A
Active IndicationsHuntington Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A